AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca Dividend Announcement
• AstraZeneca announced a semi annually dividend of $0.49 per ordinary share which will be made payable on 2024-09-09. Ex dividend date: 2024-08-09
• AstraZeneca annual dividend for 2024 was $1.48
• AstraZeneca annual dividend for 2023 was $1.43
• AstraZeneca's trailing twelve-month (TTM) dividend yield is 2.2%
• AstraZeneca's payout ratio for the trailing twelve months (TTM) is 71.25%
• AstraZeneca's dividend growth over the last five years (2018-2023) was 0.42% year
• AstraZeneca's dividend growth over the last ten years (2013-2023) was -6.50% year
AstraZeneca Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2024-08-09 | $0.49 | semi annually | 2024-09-09 |
| 2024-02-22 | $0.98 | semi annually | 2024-03-25 |
| 2023-08-10 | $0.47 | semi annually | 2023-09-11 |
| 2023-02-23 | $0.96 | semi annually | 2023-03-27 |
| 2022-08-11 | $0.46 | semi annually | 2022-09-12 |
| 2022-02-24 | $0.96 | semi annually | 2022-03-28 |
| 2021-08-12 | $0.44 | semi annually | 2021-09-13 |
| 2021-02-25 | $0.95 | semi annually | 2021-03-29 |
| 2020-08-13 | $0.44 | semi annually | 2020-09-14 |
| 2020-02-27 | $0.95 | semi annually | 2020-03-30 |
| 2019-08-08 | $0.45 | semi annually | 2019-09-09 |
| 2019-02-28 | $0.95 | semi annually | 2019-03-27 |
| 2018-08-09 | $0.45 | semi annually | 2018-09-10 |
| 2018-02-15 | $0.95 | semi annually | 2018-03-19 |
| 2017-08-09 | $0.45 | semi annually | 2017-09-11 |
| 2017-02-15 | $0.95 | semi annually | 2017-03-20 |
| 2016-08-10 | $0.45 | semi annually | 2016-09-12 |
| 2016-02-17 | $0.95 | semi annually | 2016-03-21 |
| 2015-08-12 | $0.45 | semi annually | 2015-09-14 |
| 2015-02-18 | $1.90 | semi annually | 2015-03-23 |
| 2014-08-13 | $0.90 | semi annually | 2014-09-15 |
| 2014-02-19 | $1.90 | semi annually | 2014-03-24 |
| 2013-08-14 | $0.90 | semi annually | 2013-09-16 |
| 2013-02-13 | $1.90 | semi annually | 2013-03-18 |
AstraZeneca Dividend per year
AstraZeneca Dividend growth
AstraZeneca Dividend Yield
AstraZeneca current trailing twelve-month (TTM) dividend yield is 2.2%. Interested in purchasing AstraZeneca stock? Use our calculator to estimate your expected dividend yield:
AstraZeneca Financial Ratios
P/E ratio31.95
PEG ratio-29.39
P/B ratio5.10
ROE16.57%
Payout ratio71.25%
Current ratio0.93
Quick ratio0.71
Cash Ratio0.19
AstraZeneca Dividend FAQ
How much is the next AstraZeneca dividend?
AstraZeneca's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next AstraZeneca dividend. The next AstraZeneca dividend will be released in February, or August.
When is AstraZeneca dividend paid?
AstraZeneca pays dividends on a semi annually basis. The specific dates may vary each year but are generally around February, and August. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does AstraZeneca pay?
The specific amount of AstraZeneca dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find AstraZeneca's dividend history.
Does AstraZeneca stock pay dividends?
Yes, AstraZeneca does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find AstraZeneca's dividend history.
How much dividend does AstraZeneca pay?
AstraZeneca paid $1.475 in 2024, $1.43 in 2023, $1.42 in 2022, $1.39 in 2021, and $1.39 in 2020.
How often does AstraZeneca pay dividends?
AstraZeneca typically pays dividends on a semi annually basis. This means that dividends are usually distributed 2 times a year. The specific payout dates may vary each year but generally fall around February, and August.
What is AstraZeneca's dividend yield?
The current dividend yield for AstraZeneca is 2.2%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate AstraZeneca's exact dividend yield.
When does AstraZeneca go ex dividend?
AstraZeneca's ex-dividend date for the latest dividend was on 2024-08-09. AstraZeneca typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next AstraZeneca dividend paid?
AstraZeneca pays dividends on a semi annually basis, typically around February, or August, but the exact dates can vary each year.
Will AstraZeneca increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether AstraZeneca will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is AstraZeneca dividend per share?
AstraZeneca paid $1.475 per share in 2024 and $1.43 per share in 2023. The amount of dividend per share that AstraZeneca pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is AstraZeneca a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is AstraZeneca a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is AstraZeneca a dividend stock?
Yes, AstraZeneca is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is AstraZeneca a good dividend stock?
Whether AstraZeneca is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. AstraZeneca has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating AstraZeneca as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Other factors to consider when evaluating AstraZeneca as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does AstraZeneca pay dividends monthly?
AstraZeneca typically pays dividends on a semi annually basis.
Does AstraZeneca pay dividends quarterly?
AstraZeneca currently pays dividends on a semi annually basis.
Has AstraZeneca ever paid a dividend?
Yes, AstraZeneca has a history of paying dividends to its shareholders. AstraZeneca is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy AstraZeneca dividend stocks?
To buy AstraZeneca you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy AstraZeneca stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy AstraZeneca stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does AstraZeneca pay dividends 2024?
AstraZeneca pays dividends on a semi annually basis. 2024 dividend payments are in 2024-09-09. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will AstraZeneca increase its dividend in 2024?
Decisions regarding AstraZeneca dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date AstraZeneca dividend overview you can look into the above table of dividend history.
How AstraZeneca dividend works?
The AstraZeneca dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how AstraZeneca's dividend process works:
1. Determination of Dividend: AstraZeneca's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, AstraZeneca publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, AstraZeneca distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from AstraZeneca are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Determination of Dividend: AstraZeneca's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, AstraZeneca publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, AstraZeneca distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from AstraZeneca are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are AstraZeneca dividends paid?
AstraZeneca dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: AstraZeneca sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, AstraZeneca distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: AstraZeneca declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
1. Record Date: AstraZeneca sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, AstraZeneca distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: AstraZeneca declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does AstraZeneca pay dividends?
AstraZeneca typically pays dividends on a semi annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does AstraZeneca pay dividends?
The general pattern is that AstraZeneca pays dividends around February, and August. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is AstraZeneca dividend safe?
The safety of AstraZeneca's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of AstraZeneca's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review AstraZeneca's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.
To assess the safety of AstraZeneca's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review AstraZeneca's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.